Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $69,453.75 +3.99%
Ethereum $2,143.50 +5.65%
BNB $604.89 +2.74%
Optimism $0.11 +6.62%
Arbitrum $0.10 +8.59%
Solana $82.37 +4.39%
Polygon $0.22 +2.77%
Cosmos $1.74 +3.75%
Avalanche $9.38 +6.90%

Bitcoin $69,453.75 +3.99%
Ethereum $2,143.50 +5.65%
BNB $604.89 +2.74%
Optimism $0.11 +6.62%
Arbitrum $0.10 +8.59%
Solana $82.37 +4.39%
Polygon $0.22 +2.77%
Cosmos $1.74 +3.75%
Avalanche $9.38 +6.90%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B